US Medicare's planned cardiac test coverage may depress ICD (implantable cardioverter defibrillator) demand
This article was originally published in Clinica
Executive Summary
US analysts are at odds over whether Medicare's proposed plan to pay for a new cardiac test will curtail demand for implantable cardioverter defibrillators (ICDs). The Microvolt T-wave Alternans test is intended to identify those patients who are currently eligible for defibrillators, but are highly unlikely to ever need a shock.